Based on these results, I constructed a network using hematological factors such as ANC, PLT, Hb, ALC, Mo, NLR, PLR, and LMR, which have been previously associated with treatment outcomes for various cancers [21,22,23,24,25,26,27]. The gene discussed is GSTM1; the disease is cancer.